Lithium Therapy: Understanding Mothers, Metabolism, and Mood

Northwestern University IRB:STU00200026
Principal Investigator:Crystal Clark, MD, MSc

Lithium is FDA approved for the treatment Bipolar Disorder and continues to be the gold standard for treatment. Because Bipolar Disorder frequently affects women during their reproductive years, it is important for us to understand how the dose of lithium should be modified for women who are pregnant. The goal of this study, led by Dr. Crystal Clark, is to understand the need for changes in dosage level of lithium for pregnant women with a diagnosis of Bipolar Disorder. By participating in this study, you can help optimize the quality of care for women with Bipolar Disorder.  At your initial visit, you will complete a full psychiatric evaluation with Dr. Clark at no cost to you. At each subsequent visit, you will stay overnight in the clinical research unit and complete assessments to monitor your mood, as well as blood draws to monitor your Lithium levels. As compensation, you will receive reimbursement for on-site parking or public transportation, financial compensation between $85-110 for every study visit you complete, for a total of up to $570; medical consultation with Dr. Crystal Clark about the best treatment for you throughout pregnancy; gifts for you and your baby and careful monitoring of your mood symptoms throughout pregnancy at no cost to you. Compensation is available for women with children at home, to pay for babysitting services while participating in study visits.

Participants will be eligible for the study if they:

If you are interested in participating or would like to hear more information, please email research coordinator Rebecca Newmark or call 855-99-ASHER.